我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

益气养阴活血汤配合普罗帕酮治疗心律失常的疗效及对血清hs-CRP的影响*(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2018年04期
页码:
57-59,72
栏目:
临床研究
出版日期:
2019-03-25

文章信息/Info

Title:
Effect of Yiqi Yangyin Huoxue Decoction and Propafenone on Arrhythmia and its Effect on Serum hs-CRP
文章编号:
1000 - 2723(2018)04 - 0057 - 03
作者:
相建民于军会石 凡谢印军
(东海县人民医院心内科,江苏 东海 222300)
Author(s):
XIANG Jianmin YU Junhui SHI Fan XIE Yinjun
(Internal Medicine-Cardiovascular Department, Donghai County People’s Hospita, Donghai 222300, China)
关键词:
心律失常 益气养阴活血汤 普罗帕酮 临床疗效 超敏C反应蛋白
Keywords:
arrhythmia Yiqi Yangyin Huoxue Decoction Propafenone clinical efficacy hypersensitivity C reactive protein
分类号:
R259
DOI:
10.19288/j.cnki.issn.1000-2723.2018.04.013
文献标识码:
A
摘要:
目的观察益气养阴活血汤联合普罗帕酮应治疗心律失常患者的临床疗效及对血清超敏C-反应蛋白(hs-CRP)的影响。方法选取92例心律失常患者为研究对象,随机分为研究组与对照组,各46例。对照组患者给予普罗帕酮治疗,研究组在此基础上给予益气养阴活血汤治疗,评价2组临床疗效,对比治疗前后2组心功能指标、血清hs-CRP水平变化,观察2组不良反应发生情况。结果研究组与对照组患者的总有效率分别为93.48%、71.74%,2组对比差异有统计学意义(P<0.05);治疗后,研究组与对照组患者的LVESD、LVEDD均较治疗前降低,LVEF较治疗前升高(P<0.05),且研究组的LVESD、LVEDD低于对照组,LVEF高于对照组(P<0.05);研究组与对照组的hs-CRP水平均较治疗前降低,研究组的hs-CRP水平低于对照组(P<0.05);研究组不良反应发生率明显低于对照组(P<0.05)。结论益气养阴活血汤联合普罗帕酮治疗心律失常临床疗效明显,可下调hs-CRP水平,改善患者心功能,安全性良好。
Abstract:
Objective To explore the clinical efficacy of Yiqi Yangyin Huoxue Decoction combined with propafenone in the treatment of arrhythmia, and to analyze the effect of it on serum hypersensitivity C- reactive protein(hs-CRP). Methods 92 cases of arrhythmia in our hospital from June 2015 to December -2017 were selected and randomly divided into the study group and the control group, 46 cases in each group. The patients in the control group were treated with propafenone. On this basis, the patients in the study group were treated with Yiqi Yangyin Huoxue Decoction. After the treatment, the clinical efficacy of two groups of patients was evaluated. The changes of cardiac function index and serum hs-CRP level in the two groups before and after treatment were compared, and the incidence of adverse reactions in the two groups was observed. Results The total effective rate of the study group and the control group was 93.48% and 71.74% respectively, and the difference of the two groups was statistically significant(P<0.05). After the treatment, the LVESD and LVEDD of the study group and the control group were lower than those before the treatment, and the LVEF was higher than that before the treatment(P<0.05), and the LVESD and LVEDD in the study group were lower than those in the control group, LVEF was higher than that of the control group. In the control group(P<0.05), the level of hs-CRP in the study group and the control group was lower than that before the treatment, and the level of hs-CRP in the study group was lower than that of the control group(P<0.05), and the incidence of adverse reactions in the study group was significantly lower than that of the control group(P<0.05). Conclusion Yiqi Yangyin Huoxue Decoction combined propafenone in the treatment of arrhythmia clinical effect is significant, can reduce the level of hs-CRP, improve the patient’s heart function, and high safety, worthy of clinical promotion.

参考文献/References


[1] 张艳霞. 普罗帕酮与胺碘酮治疗心律失常的临床效果及血清hs-CRP的影响对比[J]. 临床医学研究与实践,2016,1(9):21.
[2] 陈愉安. 胺碘酮治疗心律失常的效果及对血清hs-CRP 的影响[J]. 慢性病学杂志,2014,15(5):411-412.
[3] 宋卫东. 胺碘酮联合美托洛尔静脉注射治疗快速心律失常的临床观察[J]. 中国卫生标准管理,2015(30):105-106.
[4] 林谦. 心律失常中医治疗的现状与展望[J]. 中西医结合心脑血管病杂志,2015,13(2):129-131.
[5] 付生弟,谢辉. 卡维地洛联合胺碘酮治疗心律失常的临床疗效及安全性评价[J]. 中国临床药理学杂志,2016,32(7):579-581.
[6] 曾文军,高彦文,李海涛. 普罗帕酮与胺碘酮治疗心律失常效果对比及其对血清hs-CRP 的影响[J]. 山东医药,2015,55(28):42-44.
[7] 栾伟. 心律失常的临床特征及治疗[J]. 航空航天医学杂志,2015(4):434-435.
[8] 叶钦. 胺碘酮对心律失常患者血清超敏C 反应蛋白的影响[J]. 中国现代药物应用,2015,9(6):101-103.
[9] SZYDLOWSKI L, SKIERSKA A, MARKIEWICZLOSKOT G, et al. The role of interleukin-6,its-174 G>C polymorphism and C-reactive protein in idiopathic cardiac arrhythmias in children[J]. Adv Med Sci,2013,58(2):320-325.
[10] 刘淑荣,于清华. 炙甘草汤加味治疗气阴两虚型室性早搏临床研究[J]. 长春中医药大学学报,2012,28(6):977-978.
[11] HEART RHYTHM SOCIETY OF THE CHINESE SOCIETY OF BIOMEDICAL ENGINEERING,NAO XIN TONG ZHI COMMITTEE OF THE CHINESE ASSOCIATION OF INTEGRATIVE MEDICINE. (下转第72页)(上接第59页) Expert Consensus on Wenxin Granule for Treatment of CardiacArrhythmias[J]. Chin Med J(En91),2017,130(2):203-210.
[12] 陈慧勤. 高敏C反应蛋白、脑钠肽与高血压患者左心室心肌肥厚的相关性分析[J]. 生物技术世界,2015(10):74.
[13] 李铁军. 倍他乐克联合普罗帕酮治疗更年期心律失常38例疗效观察[J]. 陕西医学杂志,2012,41(4):477-479.
[14] 张军,招煦杰,王磊,等. 急性心肌梗死中西医结合临床路径的构建与评价[J]. 医学临床研究,2011,28(8):1554-1556.
[15] 孔珊珊,鞠文翠. 比阿培南治疗急性细菌性感染的疗效及对患者血清IL-6和hs-CRP的影响[J]. 中国药房,2017,28(29):4115-4118.
[16] 孙丽,宫丽鸿. 益气养阴活血汤联合西药治疗舒张性心力衰竭(气阴两虚兼血瘀)随机平行对照研究[J]. 实用中医内科杂志,2013,27(16):26-28.
[17] 王松山. 益气养阴祛瘀法为主治疗难治性心衰32例[J]. 中国中医急症,2011,20(7):1141.
[18] 曾晓宁. 普罗帕酮与胺碘酮治疗室上性快速心律失常的疗效比较[J]. 中国中西医结合急救杂志,2016,23(5):541-542.

备注/Memo

备注/Memo:
收稿日期: 2018 - 07- 06
*基金项目: 江苏省卫生厅重点科研课题(K201109)
第一作者简介: 相建民(1977-),男,硕士,主治医师,研究方向:冠心病介入治疗。
更新日期/Last Update: 2018-10-30